Bayer Statement on Final Brief Regarding the Petition for Writ of Certiorari in Hardeman
Bayer today issued the following statement on its final brief regarding its Petition for a Writ of Certiorari in Hardeman.
May 23, 2022
Bayer today issued the following statement on its final brief regarding its Petition for a Writ of Certiorari in Hardeman.
Bayer today issued the following statement on the Solicitor General’s Amicus Brief in the Hardeman appeal.
Bayer today released the following statement on the Shelton Roundup™ product liability trial before Judge Charles H. McKenzie in the Circuit Court of Jackson County, Missouri at Kansas City.
Today Monsanto filed a petition for certiorari with the U.S. Supreme Court in its appeal of the Pilliod verdict. Bayer’s statement on the filing is as follows.
Today the U.S. Supreme Court issued an order in Monsanto Co. v. Hardeman requesting the views of the Solicitor General on behalf of the United States. Bayer issued the following statement in response.
Bayer today released the following statement on the defense verdict in Stephens.
Bayer today released the following statement on the verdict in the Clark trial in the Superior Court of California, County of Los Angeles.
Bayer today released the following statement on the beginning of the Clark Trial in the Superior Court of California, County of Los Angeles.
Today Bayer – through its subsidiary Monsanto – filed its Petition for a Writ of Certiorari with the U.S. Supreme Court in Hardeman, the only Roundup™ federal product liability case to have gone to trial.
Bayer today released the following statement on decision in the Pilliod appeal before the Court of Appeal of the State of California.
Bayer today provided an update on its five-point plan to address future Roundup™ litigation risk after its May 27th decision to withdraw from the national class process. The company is now in more control of important aspects of the risk mitigation process and has sketched out two basic scenarios going forward to provide a path to closure of this litigation. The first scenario is based on obtaining a favorable decision by the United States Supreme Court on a cross-cutting issue like federal preemption which would effectively and largely end the U.S. Roundup™ litigation. The second scenario assumes that the Supreme Court either declines to hear the Hardeman case or issues a ruling in favor of plaintiff – in that case the company would activate its own claims administration program.
Read about the five-point plan here.